Jefferies Upgrades Vanda Pharmaceuticals (VNDA) to Buy; Giving Credit for Tasimelteon

February 14, 2013 6:57 AM

Jefferies upgraded Vanda Pharmaceuticals (NASDAQ: VNDA) from Hold to Buy with a price target of $6.00 (from $3.50).

The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found